Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127992021 | 12799202 | 1 | I | 20160531 | 20160916 | 20160930 | 20160930 | PER | US-009507513-1609USA008495 | MERCK | 0.00 | M | Y | 0.00000 | 20160930 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127992021 | 12799202 | 1 | PS | SINEMET | CARBIDOPALEVODOPA | 1 | Oral | UNK | 17555 | TABLET | |||||||||
| 127992021 | 12799202 | 2 | SS | DUOPA | CARBIDOPALEVODOPA | 1 | Parenteral | GASTROENTERAL SUSPENSION, PERCUTANEOUS, J-TUBE | 0 | ||||||||||
| 127992021 | 12799202 | 3 | SS | DUOPA | CARBIDOPALEVODOPA | 1 | Parenteral | GASTROENTERAL SUSPENSION, PERCUTANEOUS, J-TUBE | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127992021 | 12799202 | 1 | Parkinson's disease |
| 127992021 | 12799202 | 2 | Parkinson's disease |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127992021 | 12799202 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127992021 | 12799202 | 2 | 201605 | 201605 | 0 | |
| 127992021 | 12799202 | 3 | 20160531 | 0 |